Associate Professor, Medicine, Duke University School of Medicine

Oncology

Jeffrey Peppercorn works in the field of Oncology. He went to Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Jeffrey Peppercorn is a published doctor. He published 33 publications, including: 'ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.' He accepts all Medicare patients.

Publications

---

• ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.
• In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
• Polls and policy: signals or substance.
• Patient Experience and Attitudes Toward Addressing the Cost of Breast Cancer Care.
• The financial burden of Cancer care: do patients in the US know what to expect?
• Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult Cancer patients.
• Patient-oncologist cost communication, financial distress, and medication adherence.
• Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast Cancer survivors taking adjuvant endocrine therapy.
• Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer.
• Does comparative effectiveness research promote rationing of Cancer care?
• Early palliative care in Cancer treatment: rationale, evidence and clinical implications.
• Rationing in urologic oncology: Lessons from sipuleucel-T for advanced prostate Cancer.
• Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer.
• Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast Cancer patients receiving neoadjuvant chemotherapy.
• Safety and efficacy of aerobic training in operable breast Cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial.
• Pharmacogenetic testing in the face of unclear clinical efficacy: Lessons from cytochrome P450 2D6 for tamoxifen.
• Physician and Stakeholder Perceptions of Conflict of Interest Policies in Oncology.
• Multidisciplinary care of patients with early-stage breast Cancer.
• The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience.
• Promise and perils of guidelines in quality Cancer care.
• Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.
• Ethics of ongoing Cancer care for patients making risky decisions.
• Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast Cancer patients.
• Ethical aspects of participation in the Database of Genotypes and Phenotypes of the National Center for Biotechnology Information: The Cancer and Leukemia Group B Expe...
• Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study.
• Health literacy and Cancer risk perception: implications for genomic risk communication.
• Self-reported practices and attitudes of US oncologists regarding off-protocol therapy.
• The ethics of clinical trials for Cancer therapy.
• Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
• Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast Cancer.
• Self-reported financial burden and satisfaction with care among patients with Cancer.
• Symptom communication in breast Cancer: relationships of holding back and self-efficacy for communication to symptoms and adjustment.

Schools

---

• Harvard Medical School

• Brigham and Women39s Hospital

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Antiphospholipid Syndrome (APS)
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• Brigham and Women's Hospital
• Massachusetts General Hospital
• Harvard Medical School

Hospital

---

• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1053471599
NPPES Provider LastName		PEPPERCORN
NPPES Provider FirstName		JEFFREY
NPPES Provider ZIPCode		275990001
NPPES Provider State		NC
Specialty Description		Hematology/Oncology
Total Claim Count		406.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1053471599
Last Name Of The Provider	PEPPERCORN
First Name Of The Provider	JEFFREY
View All

Similar Doctors

---

	Dr. Aparna Raj, MD This Doctor is OpenDoctor Recommended.
	Dr. Geoffrey Liu, MD
	Dr. Hanno R. Hock, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert C. Lindsley Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Othon Iliopoulos, MD This Doctor is OpenDoctor Recommended.
	Dr. Jane A. Healy, MD This Doctor is OpenDoctor Recommended.
	Dr. David B. Sykes, MD This Doctor is OpenDoctor Recommended.
	Dr. Kinsey A. McCormick, MD This Doctor is OpenDoctor Recommended.
	Dr. Myles A. Brown, MD This Doctor is OpenDoctor Recommended.
	Dr. Janet L. Abrahm, MD
	Dr. Ann H. Partridge, MD This Doctor is OpenDoctor Recommended.
	Dr. Ephraim P. Hochberg, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christina I. Herold, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan Moody, MD This Doctor is OpenDoctor Recommended.
	Dr. Joyce F. Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. Brett Glotzbecker, MD This Doctor is OpenDoctor Recommended.
	Dr. Edwin Choy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rachel A. Freedman, MD This Doctor is OpenDoctor Recommended.
	Dr. David H. Chui, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog